The promise and limits of cancer immunotherapy @TEDMED
The promise and limits of cancer immunotherapy  @TEDMED
Uploaded September 2018 | Updated November 2026, 12 minutes ago
Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease. 

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.
The promise and limits of cancer immunotherapyHow organoids helped unravel the mystery of the Zika virusWhat if trust were the key operating measure in healthcare?Long COVID and other post-acute infection syndromes with Lisa SandersWhy its so hard to make healthy decisionsWhat vaccinating vampire bats can teach us about pandemicsHow Do We Make Health Information Clear? | James Hamblin | TEDMED In ContextThe 20th U.S. Surgeon General’s perspectives on the nation’s biggest health issuesWhat is health for?On becoming a diagnosis detective with Lisa Sanders, MD, FACPHow Doctors Learn When a Diagnosis Was Wrong | TEDMED SparkThe surprising science of alpha males
TEDMED |

The promise and limits of cancer immunotherapy

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER